Effects of aging on accompanying intermittent hypoxia in a bleomycin-induced pulmonary fibrosis mouse model

被引:0
|
作者
Lee, Heayon [1 ]
Kim, In Kyoung [1 ,2 ]
Im, Jeonghyeon [1 ]
Jin, Bae Suk [1 ]
Kim, Hwan Hee [1 ]
Kim, Sei Won [1 ]
Yeo, Chang Dong [1 ]
Lee, Sang Haak [1 ,2 ,3 ]
机构
[1] Catholic Univ Korea, Eunpyeong St Marys Hosp, Coll Med, Div Pulm Crit Care & Sleep Med,Dept Internal Med, Seoul, South Korea
[2] Catholic Univ Korea, Canc Res Inst, Coll Med, Seoul, South Korea
[3] Catholic Univ Korea, Eunpyeong St Marys Hosp, Div Pulm Crit Care & Sleep Med, Dept Internal Med,Coll Med, 1021 Tongil Ro, Seoul 03312, South Korea
来源
KOREAN JOURNAL OF INTERNAL MEDICINE | 2023年 / 38卷 / 06期
关键词
Elderly; Fibrosis; Hypoxia; Inflammation; Mice; Model; OBSTRUCTIVE SLEEP-APNEA; INFLAMMATION; SENESCENCE; DISORDERS; HALLMARKS; IMMUNITY; DISEASE;
D O I
10.3904/kjim.2023.090
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: Obstructive sleep apnea (OSA) is prevalent in older patients with idiopathic pulmonary fibrosis (IPF); however, it is underrecognized. OSA is characterized by intermittent hypoxia (IH) and sleep fragmentation. In this study, we evaluated the effects of IH in an older mouse model of bleomycin-induced lung fibrosis. Methods: Bleomycin-induced mice (C57BL/6, female) were randomly divided into four groups of young vs. old and room air (RA)-exposed vs. IH-exposed. Mice were exposed to RA or IH (20 cycles/h, FiO2 nadir 7 +/- 0.5%, 8 h/day) for four weeks. The mice were sacrificed on day 28, and blood, bronchoalveolar lavage (BAL) fluid, and lung tissue samples were obtained.Results: The bleomycin-induced IH-exposed (EBI) older group showed more severe inflammation, fibrosis, and oxidative stress than the other groups. The levels of inflammatory cytokines in the serum and BAL fluid increased in the EBI group. Hydroxyproline levels in the lung tissue increased markedly in the EBI group.Conclusions: This study demonstrates the possible harmful impact of OSA in an elderly mouse model of lung fibrosis. This study further suggests that older patients with IPF and OSA may be more of a concern than younger patients with IPF. Further research is required in this area.
引用
收藏
页码:934 / 944
页数:11
相关论文
共 50 条
  • [41] Involvement of microRNAs in the development of the bleomycin-induced pulmonary fibrosis model
    Pitozzi, V
    Caruso, P.
    Pittelli, M. G.
    Pontis, S.
    Bonatti, M.
    Ruscitti, F.
    Civelli, M.
    Trevisani, M.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [42] Effects of macrophage transplantation in bleomycin-induced pulmonary fibrosis in mice
    Suzuki, Eiko
    Ikari, Jun
    Katsumata, Megumi
    Suzuki, Masaki
    Shimada, Ayako
    Tanaka, Nozomi
    Yamamoto, Keiko
    Sekine, Ayumi
    Kasuya, Yoshitoshi
    Tatsumi, Koichiro
    Suzuki, Takuji
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [43] Effects of simvastatin on bleomycin-induced pulmonary fibrosis in female rats
    Tulek, Baykal
    Kiyan, Esen
    Kiyici, Aysel
    Toy, Hatice
    Bariskaner, Hulagu
    Suerdem, Mecit
    [J]. BIOLOGICAL RESEARCH, 2012, 45 (04) : 345 - 350
  • [44] Preventive effects of Ramelteon on bleomycin-induced pulmonary fibrosis in mice
    Zhang, Lei
    Cheng, Ting
    Chen, Wenxian
    Zhong, Changsheng
    Li, Mengyang
    Xie, Yilin
    Deng, Qin
    Wang, Huifang
    Yang, Zhenbo
    Ju, Jin
    Liang, Haihai
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (06) : 4165 - 4181
  • [45] Grape seed extract ameliorates bleomycin-induced mouse pulmonary fibrosis
    Liu, Qi
    Jiang, Jun-xia
    Liu, Ya-nan
    Ge, Ling-tian
    Guan, Yan
    Zhao, Wei
    Jia, Yong-liang
    Dong, Xin-wei
    Sun, Yun
    Xie, Qiang-min
    [J]. TOXICOLOGY LETTERS, 2017, 273 : 1 - 9
  • [46] Ameliorative Effects of Atorvastatin on Bleomycin-Induced Pulmonary Fibrosis in Rats
    Hemmeti, Ali Asghar
    Zerafatfard, Mohammad Rahim
    Goudarzi, Mehdi
    Khodayar, Mohammad Javad
    Rezaie, Anahita
    Nooshabadi, Mohammad Reza Rashidi
    Kiani, Milad
    [J]. JUNDISHAPUR JOURNAL OF NATURAL PHARMACEUTICAL PRODUCTS, 2016, 11 (04)
  • [47] Inhibitory effects of somatostatin analogue in bleomycin-induced pulmonary fibrosis
    Hosono, Tatsuya
    Bando, Masashi
    Mizushina, Yoshiko
    Sata, Masafumi
    Hagiwara, Koichi
    Sugiyama, Yukihiko
    [J]. EXPERIMENTAL LUNG RESEARCH, 2021, 47 (06) : 280 - 288
  • [48] Inhibitory effects of neferine on bleomycin-induced pulmonary fibrosis in mice
    Zhao, Libo
    Wang, Xiaomin
    Chang, Qing
    Wang, Jialing
    [J]. ACTA PHARMACOLOGICA SINICA, 2006, 27 : 386 - 386
  • [49] A translational value of pulmonary function tests in a mouse model of bleomycin-induced pulmonary fibrosis: effects of approved therapies Nintedanib and Pirfenidone
    Anzulovic, Zeljka
    Antolic, Maja
    Ognjenovic, Anja
    Cuzic, Snjezana
    Glojnaric, Ines
    Hrvacic, Boska
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [50] Comparison of expression of napsin A and surfactant protein D in bleomycin-induced pulmonary fibrosis mouse model
    Samukawa, Takuya
    Hamada, Tsutomu
    Kumamoto, Tomohiro
    Tsukuya, Go
    Kubota, Shingo
    Watanabe, Masaki
    Inoue, Hiromasa
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42